Abstract
BACKGROUND: The aim of the present study was to identify risk factors for linezolid-nonsusceptible coagulase-negative staphylococci (CNS) dissemination in the intensive care unit.
METHODS: Among the 246 patients included, 33 revealed a linezolid-nonsusceptible CNS-positive culture specimen, 68 were positive for linezolid-susceptible CNS and 145 served as controls. Isolates were characterized by phenotypic and genotypic methods to species level, susceptibility to antistaphylococcal agents and clones.
RESULTS: Among the 33 linezolid-nonsusceptible CNS patients, 29 revealed Staphylococcus epidermidis and 4 Staphylococcus capitis. All S. epidermidis strains belonged to the ST22 clone (by multilocus sequence typing), 26 carried both C2534T and T2504A and 3 strains were C2543T mutations. S. capitis strains were stratified as a common pulsed-field gel electrophoresis type and carried the G2576T mutation. Risk factors for linezolid-nonsusceptible CNS isolation were linezolid administration and mean number of linezolid-nonsusceptible CNS-positive patients in nearby beds per day.
CONCLUSIONS: These results reinforce the aspect of rational antibiotic usage, but also highlight the need for strict infection control measures to prevent the dissemination of linezolid-nonsusceptible CNS.
Original language | English |
---|---|
Pages (from-to) | 420-426 |
Number of pages | 7 |
Journal | Chemotherapy |
Volume | 59 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2013 |
Externally published | Yes |
Keywords
- Acetamides/pharmacology
- Adult
- Aged
- Anti-Bacterial Agents/pharmacology
- Coagulase/genetics
- Cohort Studies
- Female
- Humans
- Intensive Care Units
- Linezolid
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Mutation
- Oxazolidinones/pharmacology
- Phenotype
- RNA, Ribosomal, 23S/genetics
- Retrospective Studies
- Risk Factors
- Staphylococcal Infections/drug therapy
- Staphylococcus/drug effects